File Download

There are no files associated with this item.

Supplementary

Conference Paper: Metabolic dysfunction-associated steatotic liver disease is a risk factor for lower vaccine immunogenicity against SARS-COV-2 omicron variant among three-dose BNT162b2 recipients

TitleMetabolic dysfunction-associated steatotic liver disease is a risk factor for lower vaccine immunogenicity against SARS-COV-2 omicron variant among three-dose BNT162b2 recipients
Authors
Lam, LKTan, JTSeto, WKYuen, MFCheung, KS
Issue Date20-Jan-2024
Persistent Identifierhttp://hdl.handle.net/10722/339963

 

DC FieldValueLanguage
dc.contributor.authorLam, LK-
dc.contributor.authorTan, JT-
dc.contributor.authorSeto, WK-
dc.contributor.authorYuen, MF-
dc.contributor.authorCheung, KS-
dc.date.accessioned2024-03-11T10:40:39Z-
dc.date.available2024-03-11T10:40:39Z-
dc.date.issued2024-01-20-
dc.identifier.urihttp://hdl.handle.net/10722/339963-
dc.languageeng-
dc.relation.ispartofMedical Research Conference, the University of Hong Kong (20/01/2024-20/01/2024, , , Hong Kong)-
dc.titleMetabolic dysfunction-associated steatotic liver disease is a risk factor for lower vaccine immunogenicity against SARS-COV-2 omicron variant among three-dose BNT162b2 recipients-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats